2-(2-fluorophenyl)-N-(4-(2-fluoropyridin-4-yl)thiazol-2-yl)acetamide

ID: ALA5203167

PubChem CID: 24830408

Max Phase: Preclinical

Molecular Formula: C16H11F2N3OS

Molecular Weight: 331.35

Names and Identifiers

Canonical SMILES:  O=C(Cc1ccccc1F)Nc1nc(-c2ccnc(F)c2)cs1

Standard InChI:  InChI=1S/C16H11F2N3OS/c17-12-4-2-1-3-10(12)8-15(22)21-16-20-13(9-23-16)11-5-6-19-14(18)7-11/h1-7,9H,8H2,(H,20,21,22)

Standard InChI Key:  NLVGPTZAAUCTJS-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 23 25  0  0  0  0  0  0  0  0999 V2000
   34.4335  -21.3956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9181  -22.5924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9169  -23.4119    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.6250  -23.8209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3346  -23.4115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.3318  -22.5888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6232  -22.1836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0376  -22.1751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7854  -22.5046    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.3299  -21.8952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9186  -21.1890    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   31.1200  -21.3621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1429  -21.9776    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.6208  -21.3147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2856  -20.5694    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.7690  -22.1423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2896  -22.8007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6241  -23.5454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.4380  -23.6283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9162  -22.9604    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5790  -22.2183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0531  -21.5527    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   29.6248  -24.6381    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12  8  2  0
  6  8  1  0
 10 13  1  0
 13 14  1  0
 14  1  1  0
 14 15  2  0
  1 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 21 22  1  0
  4 23  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA5203167

   2-(2-fluorophenyl)-N-[4-(2-fluoropyridin-4-yl)-1,3-thiazol-2-yl]acetamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 331.35

Molecular Weight (Monoisotopic): 331.0591

AlogP: 3.66

#Rotatable Bonds: 4

Polar Surface Area: 54.88

Molecular Species: NEUTRAL

HBA: 4

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 4

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 7.91

CX Basic pKa: ┄

CX LogP: 3.88

CX LogD: 3.77

Aromatic Rings: 3

Heavy Atoms: 23

QED Weighted: 0.74

Np Likeness Score: -2.45

References

1. Come JH, Senter TJ, Clark MP, Court JJ, Gale-Day Z, Gu W, Krueger E, Liang J, Morris M, Nanthakumar S, O'Dowd H, Maltais F, Iyer G, Andreassi J, Boucher C, Considine T, Moody CS, Taylor W, Mohanty AK, Huang Y, Zuccola H, Coll J, Bonanno KC, Gagnon KJ, Gan L, Lu F, Gao H, Chakilam A, Engtrakul J, Song B, Crawford D, Doyle E, Kramer T, Vought B, Phillips J, Kemper R, Sanders M, Swett R, Furey B, Winquist R, Bunnage ME, Jackson KL, Charifson PS, Magavi SS..  (2021)  Discovery and Optimization of Pyrazole Amides as Inhibitors of ELOVL1.,  64  (24.0): [PMID:34748351] [10.1021/acs.jmedchem.1c00944]

Source

Source(1):

• Scientific Literature